The development- and phencyclidine-regulated induction of synapse-associated protein-97 gene in the rat neocortex

European Neuropsychopharmacology

Volumn 20, Issue 3, 2010, Pages 176-186

  Hiraoka, Shuichi ^a   Kajii, Yasushi ^a   Kuroda, Yasukazu ^a   Umino, Asami ^a   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Methamphetamine; N methyl D aspartate receptor; Neocortex; Phencyclidine; Schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DIZOCILPINE; HALOPERIDOL; MEMBRANE PROTEIN; MESSENGER RNA; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTOBARBITAL; PHENCYCLIDINE; SYNAPSE ASSOCIATED PROTEIN 97; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; MALE; NEOCORTEX; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSYCHOSIS; RAT; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA FINGERPRINTING; SCHIZOPHRENIA; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; MALE; MEMBRANE PROTEINS; NEOCORTEX; PHENCYCLIDINE; RATS; RATS, WISTAR; SCHIZOPHRENIA; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 75149189805     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.08.007     Document Type: Article

References (65)

1. American Psychiatric Association. Schizophrenia and other psychotic disorders. In: American Psychiatric Association (Ed). Diagnostic and Statistical Manual of Mental Disorders. 4th ed (2000), American Psychiatric Association, Washington, DC 297-343
2. Becker-Andre M., and Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res. 17 (1989) 9437-9446
3. Deakin J.F., Slater P., Simpson M.D., Gilchrist A.C., Skan W.J., Royston M.C., Reynolds G.P., and Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52 (1989) 1781-1786
4. Dong H., O'Brien R.J., Fung E.T., Lanahan A.A., Worley P.F., and Huganir R.L. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386 (1997) 279-284
5. Dracheva S., McGurk S.R., and Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res. 79 868-878 (2005) 2005
6. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., St Peter H., and Olney J.W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?. Biol. Psychiatry 38 (1995) 788-796
7. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., Farber N., Wozniak D.F., and Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123 (1993) 204-215
8. Fujiyama K., Kajii Y., Hiraoka S., and Nishikawa T. Differential regulation by stimulants of neocortical expression of mrt1, arc, and homer1a mRNA in the rats treated with repeated methamphetamine. Synapse 49 (2003) 143-149
9. Hata N., Nishikawa T., Umino A., and Takahashi K. Evidence for involvement of N-methyl-d-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex. Neurosci. Lett. 120 (1990) 101-104
10. Higuchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16 (1988) 7351-7767
11. Huang J.T., Leweke F.M., Tsang T.M., Koethe D., Kranaster L., Gerth C.W., Gross S., Schreiber D., Ruhrmann S., Schultze-Lutter F., Klosterkötter J., Holmes E., and Bahn S. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS ONE 2 (2007) e756
12. Ito T., Hiraoka S., Kuroda Y., Ishii S., Umino A., Kashiwa A., Yamamoto N., Kurumaji A., and Nishikawa T. Effects of schizophrenomimetics on the expression of the CCN1 (CYR 61) gene encoding a matricellular protein in the infant and adult neocortex of the mouse and rat. Int. J. Neuropsychopharmac. 10 (2007) 717-725
13. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
14. Johnson K.M., and Jones S.M. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 707-750
15. Kajii Y., Muraoka S., Hiraoka S., Fujiyama K., Umino A., and Nishikawa T. A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. Mol. Psychiatry 8 (2003) 434-444
16. Kerwin R.W., Patel S., Meldrum B.S., Czudek C., and Reynolds G.P. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet 1 (1988) 583-584
17. Klocker N., Bunn R.C., Schnell E., Caruana G., Bernstein A., Nicoll R.A., and Bredt D.S. Synaptic glutamate receptor clustering in mice lacking the SH3 and GK domains of SAP97. Eur. J. NeuroSci. 16 (2002) 1517-1522
18. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., and Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25 (2001) 455-467
19. Levi A., Ferri G.L., Watson E., Possenti R., and Salton S.R. Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell. Mol. Neurobiol. 24 (2004) 517-533
20. Linden A.M., Vasanen J., Storvik M., Lakso M., Korpi E.R., Wong G., and Castrén E. Uncompetitive antagonists of the N-methyl-d-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex. Pharmacol. Toxicol. 88 (2001) 98-105
21. Lynch D.R., and Guttmann R.P. NMDA receptor pharmacology: perspectives from molecular biology. Curr. Drug Targets 2 (2001) 215-231
22. Mathé J.M., Nomikos G.G., Schilstrom B., and Svensson T.H. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J. Neurosci. Res. 51 (1998) 583-592
23. Meador-Woodruff J.H., and Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 31 (2000) 288-294
24. Mehta S., Wu H., Garner C.C., and Marshall J. Molecular mechanisms regulating the differential association of kainite receptor subunits with SAP90/PSD-95 and SAP97. J. Biol. Chem. 276 (2001) 16092-16099
25. Mitkus S.N., Hyde T.M., Vakkalanka R., Kolachana B., Weinberger D.R., Kleinman J.E., and Lipska B.K. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr. Res. 98 (2008) 129-138
26. Morgan J.I., and Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14 (1991) 421-451
27. Mori K., Iwao K., Miyoshi Y., Nakagawara A., Kofu K., Akiyama T., Arita N., Hayakawa T., and Nakamura Y. Identification of brain-specific splicing variants of the hDLG1 gene and altered splicing in neuroblastoma cell lines. J. Hum. Genet. 43 (1998) 123-127
28. Müller B.M., Kistner U., Veh R.W., Cases-Langhoff C., Becker B., Gundelfinger E.D., and Garner C.C. Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J. Neurosci. 15 (1995) 2354-2366
29. Nakki R., Nickolenko J., Chang J., Sagar S.M., and Sharp F.R. Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp. Neurol. 137 (1996) 234-241
30. Niethammer M., Kim E., and Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16 (1996) 2157-2163
31. Nishijima K., Kashiwa A., and Nishikawa T. Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-d-aspartate receptor. J. Neurochem. 63 (1994) 375-378
32. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., and Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22 (1996) 304-312
33. 3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci. Lett. 40 (1983) 245-250
34. O'Brien R.J., Lau L.F., and Huganir R.L. Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr. Opin. Neurobiol. 8 (1998) 364-369
35. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
36. Portera-Cailliau C., Price D.L., and Martin L.J. N-methyl-d-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J. Neurochem. 66 (1996) 692-700
37. Regalado M.P., Terry-Lorenzo R.T., Waites C.L., Garner C.C., and Malenka R.C. Transsynaptic signaling by postsynaptic synapse-associated protein 97. J. Neurosci. 26 (2006) 2343-2357
38. Reich D.L., and Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can. J. Anaesth. 36 (1989) 186-197
39. Rumbaugh G., Sia G.M., Garner C.C., and Huganir R.L. Synapse-associated protein-97 isoform-specific regulation of surface AMPA receptors and synaptic function in cultured neurons. J. Neurosci. 23 (2003) 4567-4576
40. Sakurai S., Ishii S., Umino A., Shimazu D., Yamamoto N., and Nishikawa T. Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat. J. Neurochem. 90 (2004) 1378-1388
41. Salton S.R., Fischberg D.J., and Dong K.W. Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells. Mol. Cell. Biol. 11 (1991) 2335-2349
42. Sato D., Umino A., Kaneda K., Takigawa M., and Nishikawa T. Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain. Neurosci. Lett. 239 (1997) 21-24
43. Sato J., Shimazu D., Yamamoto N., and Nishikawa T. An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. J. Neural Transm. 115 (2008) 1355-1365
44. Scalzo F.M., and Burge L.J. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology 15 (1994) 191-200
45. Scalzo F.M., and Holson R.R. The ontogeny of behavioral sensitization to phencyclidine. Neurotoxicol. Teratol. 14 (1992) 7-14
46. Schwartz R.H., and Einhorn A. PCP intoxication in seven young children. Pediatr. Emerg. Care 2 (1986) 238-241
47. Shintomi K. Effects of psychotropic drugs on methamphetamine-induced behavioral excitation in grouped mice. Eur. J. Pharmacol. 31 (1975) 195-206
48. Shirayama Y., Mitsushio H., Takahashi K., and Nishikawa T. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions. Synapse 35 (2000) 292-299
49. Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rozov A., Hvalby O., Jensen V., Paulsen O., Andersen P., Kim J.J., Thompson R.F., Sun W., Webster L.C., Grant S.G., Eilers J., Konnerth A., Li J., McNamara J.O., and Seeburg P.H. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92 (1998) 279-289
50. Takebayashi, H., Yamamoto, N., Umino, A., Nishikawa, T., 2009. Developmentally-regulated and thalamus-selective induction of leiomodin 2 gene by a schizophrenomimetic, phencyclidine, in the rat. Int, J, Neuropsychopharmacol. 12, 1111-1126.
51. Tanii Y., Nishikawa T., Umino A., and Takahashi K. Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci. Lett. 112 (1990) 318-323
52. Tanii Y., Nishikawa T., Hashimoto A., and Takahashi K. Stereoselective inhibition by d- and l-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res. 563 (1991) 281-284
53. Tanii Y., Nishikawa T., Hashimoto A., and Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 269 (1994) 1040-1048
54. Toth E., and Lajtha A. Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem. Res. 11 (1986) 393-400
55. Toyooka K., Iritani S., Makifuchi T., Shirakawa O., Kitamura N., Maeda K., Nakamura R., Niizato K., Watanabe M., Kakita A., Takahashi H., Someya T., and Nawa H. Selective reduction of a PDZ protein, SAP97, in the prefrontal cortex of patients with chronic schizophrenia. J. Neurochem. 83 (2002) 797-806
56. Tsuchida H., Yamamoto N., Kajii Y., Umino A., Fukui K., and Nishikawa T. Cloning of a d-serine-regulated transcript dsr-1 from the rat cerebral cortex. Biochem. Biophys. Res. Commun. 280 (2001) 1189-1196
57. Umino A., Nishikawa T., and Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem. Int. 26 (1995) 85-90
58. Umino A., Takahashi K., and Nishikawa T. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. Br. J. Pharmacol. 124 (1998) 377-385
59. Wang L., Piserchio A., and Mierke D.F. Structural characterization of the intermolecular interactions of synapse-associated protein-97 with the NR2B subunit of N-methyl-d-aspartate receptors. J. Biol. Chem. 280 (2005) 26992-26996
60. Watanabe M., Inoue Y., Sakimura K., and Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. NeuroReport 3 (1992) 1138-1140
61. Welch M.J., and Correa G.A. PCP intoxication in young children and infants. Clin. Pediatr. (Phila) 19 (1980) 510-514
62. Welsh J., Chada K., Dalal S.S., Cheng R., Ralph D., and McClelland M. Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res. 20 (1992) 4965-4970
63. Wenzel A., Fritschy J.M., Mohler H., and Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68 (1997) 469-478
64. White P.F., Way W.L., and Trevor A.J. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 56 (1982) 119-136
65. Yamamoto Y., Mizuno R., Nishimura T., Ogawa Y., Yoshikawa H., Fujimura H., Adachi E., Kishimoto T., Yanagihara T., and Sakoda S. Cloning and expression of myelin-associated oligodendrocytic basic protein. A novel basic protein constituting the central nervous system myelin. J. Biol. Chem. 269 (1994) 31725-31730